Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 19

Showing 19 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 13
Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer
Shaomin Zou, Chao Yang, Jieping Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
The Impact of Probiotics on Oral Cancer: Mechanistic Insights and Therapeutic Strategies
Lakshmi Nandhana S S, D. Maheswary, Sujith Sri Surya Ravi, et al.
Oral Oncology Reports (2025), pp. 100715-100715
Open Access | Times Cited: 1
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Exploring the prognostic role of microbial and genetic markers in lung squamous cell carcinoma
Fan Yang, Xiaodong Jia, Zihuan Ma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Shuang Bailian mixture enhanced the anti-cancer effect of cisplatin by regulating PI3K-Akt-Bcl 2 signaling pathway
Yilin Zheng, Xiaoyan Li, Guohai Huang, et al.
Journal of Ethnopharmacology (2025), pp. 119462-119462
Closed Access
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders
Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Luis D. López-Murillo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1773-1773
Open Access
The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications
Kai Xu, Zainab Motiwala, Irene Corona‐Avila, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer
Na Wang, Si Wu, Lanxiang Huang, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Intratumoral microbiota-aided fusion radiomics model for predicting tumor response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer
Yilin Chen, Yu‐Hong Huang, Wei Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Optimizing Cancer Treatment Through Gut Microbiome Modulation
Kyuri Kim, Mingyu Lee, Yoojin Shin, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1252-1252
Open Access
Path to bacteriotherapy: From bacterial engineering to therapeutic perspectives
Jinling Liu, Chongsheng He, Wenzhi Tan, et al.
Life Sciences (2024) Vol. 352, pp. 122897-122897
Closed Access | Times Cited: 3
Disentangling the molecular mystery of tumour–microbiota interactions: Microbial metabolites
Y. Duan, Jia‐Hao Dai, Ying‐Qi Lu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 2
Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions
Feiyang Luo, Xinyue Wang, Chun Ye, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 1
The role of metabolic reprogramming in immune escape of triple-negative breast cancer
Ruochen Bao, Hongtao Qu, Baifeng Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Investigating the Role of the Intratumoral Microbiome in Thyroid Cancer Development and Progression
Hanieh Ataollahi, Mehdi Hedayati, Noosha Zia-Jahromi, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104545-104545
Closed Access
Crosstalk Between the Intratumoral Microbiota and the Tumor Microenvironment: New Frontiers in Solid Tumor Progression and Treatment
Qing Zhou, Lijun Zhou, Xi Chen, et al.
Cancer Reports (2024) Vol. 7, Iss. 11
Open Access
Harnessing the gut microbiome to enhance cancer immunotherapy: Current advances and future directions in microbiota‐based therapeutic strategies
Binyan Zhao, Bailing Zhou, Qing Li, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Open Access
Page 1

Scroll to top